The growing proliferation of generic drugs has intensified pharma industry competition for both physician and patient brand loyalty. In a sea of increasing “sameness” – the delivery device – not the commoditized drug is fast becoming the most meaningful point of differentiation among pharmaceutical companies.
How can the Pharma Industry Leverage the Patient Journey to drive transformative innovation?
May 13th, 2014
The growing proliferation of generic drugs has intensified pharma industry competition for both physician and patient brand loyalty. In a sea of increasing “sameness” – the delivery device – not the commoditized drug is fast becoming the most meaningful point of differentiation among pharmaceutical companies.
Take for example, cases of self-drug administration by those with special cognitive or physical limitations, such as autoimmune disease. The patient’s ease-of-use and favorable experience with a strategically-designed drug delivery device not only increases their prescription refill adherence and device loyalty, but also drives physicians’ confidence level in the brand and, ultimately – higher volume prescription rates.
Meet with Insight thought leaders one-on-one at MD&M East, held June 10-12 at New York’s Javits Center to learn more about how taking a longitudinal view of how user needs evolve over time can ensure developers define new delivery systems in a way that will drive adherence and, ultimately – brand loyalty.
To set up a time to talk, please contact Mark Tunkel at [email protected], or 773.907.0100 extension 220.